Answers are grounded in this paper and cite their sources.
Observational study shows increased cardiovascular risk in acute coronary syndrome patients with higher lipoprotein(a) levels, suggesting implications for OSA treatment efficacy.
OSA was associated with a continuously increased cardiovascular risk and a higher prevalence of HRP features as Lp(a) levels rose. Lp(a) may help identify ACS patients at higher cardiovascular risk, in whom the efficacy of OSA treatment should be further investigated.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: